Skip to main content
SHIELD THERAPEUTICS PLC logo

SHIELD THERAPEUTICS PLC — Investor Relations & Filings

Ticker · STX ISIN · GB00BYV81293 LEI · 213800G74QWY15FC3W71 IL Manufacturing
Open in API
Filings indexed 408 across all filing types
Latest filing 2021-04-06 Regulatory Filings
Country GB United Kingdom
Listing IL STX

About SHIELD THERAPEUTICS PLC

https://www.shieldtherapeutics.com/

Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on addressing iron deficiency. The company's mission is to improve the lives of patients suffering from this condition, with or without anemia. Its lead product is Accrufer® (ferric maltol), also marketed as Feraccru®, a novel, stable, non-salt-based oral therapy. This innovative pharmaceutical is broadly indicated for use in adults across multiple therapeutic categories, aiming to provide an effective and well-tolerated treatment for a significant unmet medical need.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number' and is distributed via 'RNS, the news service of the London Stock Exchange.' It announces a 'Price Monitoring Extension' for a security, which is a routine operational update related to trading mechanisms. This type of short, specific regulatory announcement that doesn't fit into the major financial reporting categories (like 10-K, ER, IR) is best classified under the general regulatory announcement category, RNS. The document length is short (1921 chars), and it is a direct announcement, not a link to a larger report.
2021-04-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and is issued via 'RNS Number : 4090U' by Shield Therapeutics PLC. The content explicitly details changes in voting rights ('An event changing the breakdown of voting rights') and reports the resulting shareholding percentage (25.95%) and total number of shares held by a specific entity ('W. Health L.P.'). This structure perfectly matches the definition of a Major Shareholding Notification, which is classified under the code MRQ in the provided schema.
2021-04-06 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement released via RNS (the news service of the London Stock Exchange), indicated by the 'RNS Number' header and the concluding boilerplate text. The content explicitly states the 'Total Voting Rights Update' as of March 31, 2021, referencing FCA's Disclosure and Transparency Rule 5.6.1 and providing the total number of issued shares (215,837,965). This type of mandatory disclosure regarding the total number of shares and voting rights is a standard regulatory filing. Since it is a specific regulatory update that doesn't fit perfectly into the other defined categories (like DIRS, DIV, or SHA, which are more specific), and it is presented as a formal regulatory news service release, the most appropriate general category is Regulatory Filings (RNS). It is not a full report (10-K, IR) nor a specific shareholder vote result (DVA).
2021-03-31 English
Block Listing 6 Monthly Return
Regulatory Filings Classification · 95% confidence The document is identified by the header 'RNS Number : 1728U' and contains information related to the 'Block Listing 6 Monthly Return' for Shield Therapeutics PLC, covering the period from October 1, 2020, to March 31, 2021. This filing details the balance and movement of unallotted securities under various share schemes (Retention Share Plan, Option Plan, Incentive Plan, etc.). This type of periodic return concerning the issuance or allotment of shares under employee/incentive schemes, especially when filed via RNS (London Stock Exchange news service), strongly suggests a regulatory filing related to capital structure or share movements. While it touches upon share capital, it is a specific regulatory return rather than a general capital change announcement (SHA) or a transaction in own shares (POS). Given the context of being a formal, periodic return reported via RNS, and lacking a more specific category that perfectly matches a 'Block Listing Return', the most appropriate general regulatory category is RNS, as it is a standard regulatory announcement format from the London Stock Exchange's news service.
2021-03-31 English
Investor presentation
Report Publication Announcement Classification · 99% confidence The document explicitly states its purpose in the text: 'Investor presentation' and 'Shield Therapeutics plc... announces that Tim Watts, Chief Executive Officer, will present at the Proactive One2One Virtual Investor Forum'. This clearly indicates the document is related to an investor presentation or an announcement about one. The definition for Investor Presentation (IP) is 'Detailed presentation for investors focusing on financials, strategy, and market position.' Although this specific text is an announcement about attending a forum where a presentation will occur, the core subject matter aligns best with the Investor Presentation category, as it is not a general regulatory filing (RNS) or a report publication announcement (RPA) about a formal financial report (like 10-K or IR). Given the context of a CEO presenting to investors, IP is the most specific fit.
2021-03-30 English
Study demonstrates effectiveness of ferric maltol
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number : 5235T' and contains information about a clinical study publication related to the company's product. The text explicitly states, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS...' and later, 'Reach is a non-regulatory news service.' This indicates it is a general announcement distributed via the RNS system but is explicitly non-regulatory in nature. Since it is a general announcement that doesn't fit specific categories like ER, DIV, or MANG, and it is distributed through the RNS mechanism, the most appropriate fallback category is Regulatory Filings (RNS), as it is a standard regulatory/news distribution channel announcement, even if marked as non-regulatory press release.
2021-03-26 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.